Related Experiment Video
Updated: May 15, 2026

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
Published on: June 25, 2012
[Inhibitory effect of adenovirus-mediated D2S gene plus bromocriptine therapy on primary cultures of human
Zhen-kun Xiong1, Wei-qiang Li, Jie Liu
1Department of Neurosurgery, First Affiliated Hospital, Wenzhou Medical College, China.
Objective:
To explore the inhibitory effect of non-functioning pituitary adenoma (NFPA) cells after a combined treatment of adenovirus mediated D2S gene and bromocriptine in vitro.
Methods:
Adenovirus containing dopamine 2 receptor short isoform (D2S) gene was used to infect NFPA cells. The transfection of D2S gene into NFPA cells was confirmed by immunofluorescence. And cell apoptosis of infected cells treated by bromocriptine was evaluated with CCK-8 assay in vitro.
Results:
When D2S gene transfection and bromocriptine was used in combination, the survival rate of NFPA cells significantly decreased (40 ± 5)% versus the control group (97 ± 5)% and the pAd-EGFP transfection combined bromocriptine treatment group (90 ± 9)% (P < 0.05).
Conclusion:
The combined treatment of adenovirus-mediated D2S gene and bromocriptine can effectively induce the apoptosis of NFPA cells on primary culture and increase the sensitivity of NFPA to dopamine agonist.
Insights
Combined therapy using adenovirus-mediated dopamine 2 receptor short isoform (D2S) gene and bromocriptine effectively induces non-functioning pituitary adenoma (NFPA) cell apoptosis. This approach enhances NFPA sensitivity to dopamine agonists.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Context:
- Non-functioning pituitary adenomas (NFPAs) represent a significant portion of pituitary tumors.
- Current treatment options for NFPAs have limitations, necessitating novel therapeutic strategies.
- Understanding the molecular mechanisms underlying NFPA growth is crucial for developing targeted therapies.
Purpose:
- To investigate the synergistic inhibitory effect of adenovirus-mediated dopamine 2 receptor short isoform (D2S) gene delivery combined with bromocriptine on NFPA cells in vitro.
- To evaluate the induction of apoptosis and changes in cell viability in NFPA cells following this combined treatment.
Summary:
- Adenovirus carrying the D2S gene was used to transfect NFPA cells, with successful transfection confirmed by immunofluorescence.
- Bromocriptine treatment was administered to D2S-transfected NFPA cells, and cell apoptosis was assessed using the CCK-8 assay.
- The combination of D2S gene transfection and bromocriptine significantly reduced NFPA cell survival to (40 ± 5)% compared to control and EGFP groups.
Impact:
- This study demonstrates that the combined therapy effectively induces apoptosis in primary cultured NFPA cells.
- The findings suggest that this combination therapy increases the sensitivity of NFPAs to dopamine agonists.
- This research offers a potential novel therapeutic approach for managing non-functioning pituitary adenomas.
More Related Videos
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014